CBAY
Name
52W High
52W Low
Market Cap
Dividend Yield
Price/earnings
Tags
Biotechnology
Health Technology
Manufacturing
Pharmaceutical Preparation Manufacturing
Dividends
No dividend
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Income Statement
Total Revenue
Operating Revenue
Total Gross Profit
Total Operating Income
Net Income
EV to EBITDA
EV to Revenue
Price to Book value
Price to Earnings
Additional Data
Selling, General & Admin Expense
Research & Development Expense
Total Operating Expenses
Interest Expense
Interest & Investment Income
Other Income / (Expense), net
Earnings History
Name
52W High
52W Low
Market Cap
Dividend Yield
Price/earnings
Tags
Biotechnology
Health Technology
Manufacturing
Pharmaceutical Preparation Manufacturing
Dividends
No dividend
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Income Statement
Total Revenue
Operating Revenue
Total Gross Profit
Total Operating Income
Net Income
EV to EBITDA
EV to Revenue
Price to Book value
Price to Earnings
Additional Data
Selling, General & Admin Expense
Research & Development Expense
Total Operating Expenses
Interest Expense
Interest & Investment Income
Other Income / (Expense), net
Earnings History
CEO
Sujal Shah
Location
California, USA
Exchange
Nasdaq
Website
https://cymabay.com
Description
CymaBay Therapeutics, Inc.
CEO
Sujal Shah
Location
California, USA
Exchange
Nasdaq
Website
https://cymabay.com
Description
CymaBay Therapeutics, Inc.